Company press releases

Viser 101 - 114 av 114 resultater
Tid Selskap Tittel Sektor Kategori
23 Jul 2021
08:00 CEST 		GENEURO GeNeuro: Financial Information and Business Update for the Second Quarter 2021 20103010 Biotechnology Sales
15 Jul 2021
08:00 CEST 		GENEURO GeNeuro Announces the Publication in Multiple Sclerosis of Results From CHANGE-MS and ANGEL-MS Studies 20103010 Biotechnology Products and services
15 Jul 2021
08:00 CEST 		GENEURO GeNeuro annonce la publication dans la revue scientifique Multiple Sclerosis desrésultats des études cliniques CHANGE-MS et ANGEL-MS 20103010 Biotechnology Products and services
13 Jul 2021
08:00 CEST 		GENEURO GeNeuro annonce la réussite d’un placement privé de 6,0 millions d’euros 20103010 Biotechnology Other subject
13 Jul 2021
08:00 CEST 		GENEURO GeNeuro Announces Successful €6.0 Million Private Placement 20103010 Biotechnology Other subject
12 Jul 2021
19:40 CEST 		GENEURO GeNeuro Announces Launch of Private Placement 20103010 Biotechnology Other subject
12 Jul 2021
18:29 CEST 		GENEURO GeNeuro Announces Launch of Private Placement 20103010 Biotechnology Other subject
12 Jul 2021
18:29 CEST 		GENEURO GeNeuro annonce le lancement d’un placement privé 20103010 Biotechnology Other subject
05 Jul 2021
07:30 CEST 		GENEURO GeNeuro Presents Data Supporting Pathogenic Role of an Endogenous Retroviral Protein (HERV-W ENV) in Post-COVID Neuropsychiatric Syndrome 20103010 Biotechnology New
05 Jul 2021
07:30 CEST 		GENEURO GeNeuro présente des données soutenant le rôle pathogène d'une protéine rétrovirale endogène (HERV-W ENV) dans les syndromes neuropsychiatriques post-COVID, et annonce une collaboration avec la Fondation FondaMental pour accélérer le développement... 20103010 Biotechnology New
24 Jun 2021
07:30 CEST 		GENEURO GeNeuro et le CIRI renouvellent leur accord de collaboration et l'étendent aux syndromes post-COVID 20103010 Biotechnology Products and services
24 Jun 2021
07:30 CEST 		GENEURO GeNeuro and CIRI Renew Collaboration Agreement and Expand Focus to Post-COVID Syndromes 20103010 Biotechnology Products and services
01 Jun 2021
07:30 CEST 		GENEURO Les actionnaires de GeNeuro approuvent l’ensemble des résolutions proposées à l’Assemblée Générale Annuelle 2021 20103010 Biotechnology General meeting / Board Meeting
01 Jun 2021
07:30 CEST 		GENEURO GeNeuro Announces Approval of all Resolutions Proposed at 2021 Annual General Meeting 20103010 Biotechnology General meeting / Board Meeting